Udistrong Sachet

Udistrong sachet  contains active components called L-Isoleucine, L-Leucine and L-Valine. It improves the quality of life and nutritional status in patients with liver disorders such as nonalcoholic fatty liver disease (NAFLD), hepatic encephalopathy, and end-stage liver disease. It also promotes lean muscle growth and maintains muscle during exercise. Hepatic encephalopathy (HE) is a brain disorder caused by liver dysfunction. This medication can improve nutritional status and reduce muscle wasting in patients with hepatitis C. It can be used to promote wound healing and reduce muscle loss in patients with burn injuries.

If you are allergic to any of the ingredients in this medication, you should not take Udistrong sachet.  People with maple syrup urine disease(MSUD) should not take this medication. It should also be avoided by patients with advanced liver disease, such as those with cirrhosis and severe kidney disease. It may affect blood sugar levels. People with diabetes should monitor their blood sugar levels closely when taking this medication. L- Isoleucine + L-Leucine + L-Valine (BCAA) should be used cautiously in the elderly, especially those with underlying medical conditions. It is not recommended for children under the age of 18.